Wealth Enhancement Advisory Services LLC Raises Position in Oscar Health, Inc. $OSCR

Wealth Enhancement Advisory Services LLC increased its holdings in Oscar Health, Inc. (NYSE:OSCR) by 61.0% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,790 shares of the company’s stock after purchasing an additional 8,258 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Oscar Health were worth $467,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Jones Financial Companies Lllp increased its position in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio purchased a new position in shares of Oscar Health in the first quarter valued at about $30,000. Larson Financial Group LLC increased its position in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after acquiring an additional 2,512 shares during the period. CWM LLC increased its position in shares of Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after acquiring an additional 1,078 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of Oscar Health by 484.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock valued at $45,000 after acquiring an additional 2,854 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Up 12.4%

NYSE:OSCR opened at $21.67 on Monday. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $22.78. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The company’s 50-day simple moving average is $17.05 and its 200 day simple moving average is $15.61. The firm has a market capitalization of $5.60 billion, a P/E ratio of -26.75 and a beta of 1.89.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same quarter in the previous year, the firm posted $0.20 earnings per share. Oscar Health’s quarterly revenue was up 29.0% on a year-over-year basis. As a group, analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on OSCR shares. Baird R W cut shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 25th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Saturday, September 27th. Barclays decreased their price objective on shares of Oscar Health from $17.00 to $11.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 23rd. Raymond James Financial lowered shares of Oscar Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, June 24th. Finally, Piper Sandler cut their target price on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a research note on Thursday, August 14th. Four research analysts have rated the stock with a Hold rating and six have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Oscar Health currently has a consensus rating of “Strong Sell” and an average price target of $12.07.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the transaction, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 25.11% of the company’s stock.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.